23andMe may disclose your personal and genetic data to law enforcement, government agencies, or courts in response to valid legal requests such as subpoenas, warrants, or court orders.
This analysis describes what 23andMe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision defines the operational boundary between 23andMe's general data protection practices and mandatory disclosure obligations imposed by legal authority. It establishes that genetic and personal data held by 23andMe remains subject to compulsory legal disclosure mechanisms, regardless of the company's privacy commitments.
The updated privacy statement no longer explicitly directs users to a separate Medical Record Privacy Notice for telehealth services or explains that medical information collected through telehealth is governed by different privacy rules. Previously, the policy stated that users choosing telehealth services coordinated through 23andMe would find healthcare privacy protections described in a separate notice. That reference is now absent from the main privacy statement. Users seeking privacy information specific to telehealth services will need to determine independently whether a separate notice exists or contact 23andMe directly using the provided contact information.
View change record →The updated privacy statement no longer explicitly discloses a separate Medical Record Privacy Notice that previously described how medical information is used, disclosed, and maintained for telehealth services. Users who receive telehealth services coordinated through 23andMe may now lack clear notice of which privacy framework governs their medical records, since the reference to that parallel notice has been removed. The organizational scope change from '23andMe Research Institute' to '23andMe' narrows the explicitly named entities responsible for the policy, though operational impact depends on how these entities actually function.
View change record →Removal of explicit law enforcement disclosure provision eliminates transparency about government access to genetic data, a critical privacy safeguard previously highlighted.
View full change record →Users have no guaranteed right to be notified before their genetic data is disclosed to law enforcement, and the policy does not commit to challenging overbroad legal requests. This is particularly significant given that genetic data can implicate biological relatives who are not 23andMe customers.
How other platforms handle this
We will share individual user information with companies, organizations or individuals outside of Google if we have a good-faith belief that access, use, preservation or disclosure of the information is reasonably necessary to: meet any applicable law, regulation, legal process or enforceable govern...
By issuing a chargeback or refund request for Premium subscriptions paid for through a third party, you agree to allow Telegram to release necessary data to that third party regarding your account status and Telegram Premium purchases.
We may disclose certain information, in connection with or during negotiations or closing of any merger, sale of company assets, financing, or acquisition of all or a portion of our business to another company.
Monitoring
23andMe has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
This provision requires assessment against GDPR Article 23 restrictions on law enforcement access, CCPA exemptions for legal compliance, and HIPAA law enforcement disclosure rules applicable to telehealth data; the absence of a transparency report commitment or user notification policy is a notable gap.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 1 platform + weekly digest. Monitor: 25 platforms + same-day alerts. No credit card required.
ConductAtlas detected a major restructuring of Meta’s privacy policy that removed detailed consumer rights disclosures and relocated them to separate documents.
Your genetic data may be transferred to a new owner as a business asset. Here is what the Terms of Service actually say and what you can do right now.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
This provision defines the operational boundary between 23andMe's general data protection practices and mandatory disclosure obligations imposed by legal authority. It establishes that genetic and personal data held by 23andMe remains subject to compulsory legal disclosure mechanisms, regardless of the company's privacy commitments.
Users have no guaranteed right to be notified before their genetic data is disclosed to law enforcement, and the policy does not commit to challenging overbroad legal requests. This is particularly significant given that genetic data can implicate biological relatives who are not 23andMe customers.
ConductAtlas has identified this type of provision across 4 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by 23andMe.